Cilostazol: a review of basic mechanisms and clinical uses
RY Kherallah, M Khawaja, M Olson, D Angiolillo… - … drugs and therapy, 2022 - Springer
Primarily used in the treatment of intermittent claudication, cilostazol is a 2-oxyquinolone
derivative that works through the inhibition of phosphodiesterase III and related increases in …
derivative that works through the inhibition of phosphodiesterase III and related increases in …
Molecular mechanisms and current treatment options for cancer cachexia
Simple Summary The primary characteristics of cancer cachexia are weakness, weight loss,
atrophy, fat reduction, and systemic inflammation. Cachexia is strongly associated with …
atrophy, fat reduction, and systemic inflammation. Cachexia is strongly associated with …
Combined carvacrol and cilostazol ameliorate ethanol-induced liver fibrosis in rats: Possible role of SIRT1/Nrf2/HO-1 pathway
Carvacrol is a natural phenolic monoterpenoid, and cilostazol is a selective
phosphodiesterase-3 inhibitor with antioxidant, anti-inflammatory and antiapoptotic effects …
phosphodiesterase-3 inhibitor with antioxidant, anti-inflammatory and antiapoptotic effects …
The cardioprotective effect of Corosolic Acid in the Diabetic rats: A possible mechanism of the PPAR-γ pathway
The study was conducted to determine whether corosolic acid could protect the myocardium
of diabetic rats from damage caused by isoproterenol (ISO) and, if so, how peroxisome …
of diabetic rats from damage caused by isoproterenol (ISO) and, if so, how peroxisome …
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis
M Sohn, S Lim - International Journal of Molecular Sciences, 2024 - mdpi.com
Atherosclerotic cardiovascular disease (ASCVD) stands as the leading global cause of
mortality. Addressing this vital and pervasive condition requires a multifaceted approach, in …
mortality. Addressing this vital and pervasive condition requires a multifaceted approach, in …
PPARγ in ischemia-reperfusion injury: overview of the biology and therapy
R Huang, C Zhang, X Wang, H Hu - Frontiers in Pharmacology, 2021 - frontiersin.org
Ischemia-reperfusion injury (IRI) is a complex pathophysiological process that is often
characterized as a blood circulation disorder caused due to various factors (such as …
characterized as a blood circulation disorder caused due to various factors (such as …
Platelet Rich Plasma and Adipose-Derived Mesenchymal Stem Cells Mitigate Methotrexate-Induced Nephrotoxicity in Rat via Nrf2/Pparγ/HO-1 and NF-Κb/Keap1 …
FA Wani, MA Ibrahim, SH Ameen, AE Farage, ZAE Ali… - Toxics, 2023 - mdpi.com
Background: the nephrotoxicity of methotrexate (MTX) is observed in high-dose therapy.
Moreover, low-dose MTX therapy for rheumatic diseases is debatable and claimed to cause …
Moreover, low-dose MTX therapy for rheumatic diseases is debatable and claimed to cause …
Empagliflozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats
AT Osman, SMZ Sharkawi, MIA Hassan… - Food and Chemical …, 2021 - Elsevier
Kidney injury from chemotherapy is one of the worsening problems associated with
methotrexate (MTX) use. This work aims to examine the nephroprotective effects of …
methotrexate (MTX) use. This work aims to examine the nephroprotective effects of …
Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia via Activating PPARγ
Y Zhang, Y Zhang, Y Li, L Zhang, S Yu - Frontiers in Pharmacology, 2021 - frontiersin.org
The ongoing loss of skeletal muscle is a central event of cancer cachexia, and its
consequences include adverse effects on patient's quality of life and survival. Alpinetin (Alp) …
consequences include adverse effects on patient's quality of life and survival. Alpinetin (Alp) …
Novel insights into gut health: Cilostazol strengthens gut integrity by adjusting TLR-2/NF-κB/IL-23 and CD44/AKT/GSK-3β/cyclin-D1 trajectories in methotrexate …
SM Mansour, O Sabra, F El-Komy, K Ahmed… - European Journal of …, 2024 - Elsevier
Methotrexate (MTX)-induced gastrointestinal mucositis is a common adverse effect
characterized by redox imbalance and overproduction of inflammatory mediators that …
characterized by redox imbalance and overproduction of inflammatory mediators that …